Genta

company

About

Genta Incorporated is a biopharmaceutical company.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$8.40M
Industries
Biotechnology
Number Of Employee
1 - 10
Operating Status
Active

Genta Incorporated is a biopharmaceutical company focused on the identification, development and commercialization of drugs for the treatment of people with cancer. Genta has built a broad portfolio of proprietary products in various stages of clinical development. The Company’s drugs include Ganite (gallium nitrate injection), tesetaxel, and oral gallium.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$8.40M
Genta has raised a total of $8.40M in funding over 2 rounds. Their latest funding was raised on Aug 19, 1991 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 19, 1991 Series Unknown $8.40M 3 Detail

Investors

Number of Lead Investors
Number of Investors
3
Genta is funded by 3 investors. Biotechnology Investments and Asset Management Associates are the most recent investors.
Investor Name Lead Investor Funding Round
Biotechnology Investments Series Unknown
Asset Management Associates Series Unknown
Hook Partners Series Unknown